Cree, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

CREE 35.03 +0.02 (0.06%)
price chart
Cree, Inc. Short Interest Disclosure
The short interest in Cree, Inc. (NASDAQ:CREE) has declined from 19,445,308 on February 13,2015 to 18,239,820 on February 27,2015.
First Call Rating Update on Cree, Inc.  Ashburn Daily
Cree PT Raised to $34.00 (CREE)  The Legacy
Thursday Stock's Downfall Alert: Oi SA (ADR) (NYSE:OIBR), Cree, Inc (NASDAQ ...
Cree, Inc (NASDAQ:CREE), declined -3.87%, and closed at $35.01. The company holds the market capitalization of $4.07B.
Cree Inc. May Soon Become Interesting (CREE)
Cree, Inc.'s (NASDAQ:CREE) share price has recovered slightly after falling to $27.28 on October 22nd. Nonetheless, Cree continues to remain on a downward trend.
Cree: A Smart Way to Benefit From the Growth of LED Lighting
Related articles »  
Cree, Inc. (CREE) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Cree, Inc. (CREE - Snapshot Report). The stock has moved higher by 12.8% in the past month, while it is also above its 20 Day SMA too.
Cree, Inc. (CREE) Files ITC Complaint Against Feit Electric Company
Cree, Inc. (Nasdaq: CREE) has filed complaints with the U.S. International Trade Commission (ITC) and the U.S. District Court for the Western District of Wisconsin against Feit Electric Company, Inc. and its Asian supplier, Unity Opto Technology Co ...
Cree Inc. to sue Unity Opto for patent infringement in US  China Post
Cree Acts to Protect Its Intellectual Property in Consumer LED Lighting Market  MarketWatch
Why Dollar Tree, Avon, and Cree are 3 of Today's Best Stocks
... were up 1.5%, and the Nasdaq Composite rose nearly 1.8%. It was a good day for most stocks, but three that stood out in particular as today's best were Dollar Tree, Inc. (NASDAQ:DLTR), Avon Products, Inc. (NYSE:AVP), and Cree, Inc. (NASDAQ:CREE).
Analyst Update: BioScrip, Inc., ZIOPHARM Oncology, Inc., and Cree, Inc.
Analysts are weighing in today on biotechnology firms BioScrip Inc (NASDAQ:BIOS) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), as well as LED specialist Cree, Inc. (NASDAQ:CREE). Here's a quick look at today's brokerage notes on BIOS, ZIOP, and ...
Cree, Inc. to Webcast Upcoming Conference Presentation
Cree is a market-leading innovator of lighting-class LEDs, LED lighting and semiconductor products for power and radio-frequency (RF) applications.
Cree Continues To Look Promising (CREE)
Cree Inc (NASDAQ:CREE) reported a stable mix of consumer and commercial sales for Q2 FY 2015 driven by the company's push to increase awareness of the Cree brand.
CGE Energy Becomes CREE Elite Distributor  MarketWatch
Hold on Cree Inc (NASDAQ:CREE)
Cree, Inc. (NASDAQ:CREE) was this week reiterated as a hold by analysts at Canaccord Genuity as a hold and they also revised their 12 month price target on the stock up from $29 to $34.
Analyst Rating Update on Cree, Inc.  Markets Bureau
Cree Receives $44.15 Consensus Target Price from Analysts (NASDAQ:CREE)  Intercooler